Solana Company (HSDT) Stock Score, Valuation & Financial Research

Solana Company is in the Financial Services sector and Asset Management industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.

Quick answer for HSDT

Solana Company currently has a Wall Street Score of 34/100. The stored market price is $2.22. Its financial score is 21/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What Solana Company does

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown,

HSDT financial snapshot

Wall Street Score:
34/100
Current price:
$2.22
Market capitalization:
$129.6M
Revenue:
$9.6M
Net income:
$-136.8M
Free cash flow:
$-61.3M
Cash:
$4.4M
Total debt:
$0
EPS:
-2.34
Financial score:
21/100
Valuation score:
0/100
Revenue score:
41/100

What stands out

  • Reported year-over-year revenue growth is +0.6%.
  • Free cash flow is $-61.3M, showing cash burn in the current stored period.
  • The balance sheet shows $4.4M of cash versus $0 of total debt, leaving more cash than debt.
  • The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 21/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-08-14.

How to research HSDT

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.